LabAnalyzer is a web-based AI tool designed to help individuals understand their medical laboratory test results without requiring clinical expertise. Users upload a lab report in PDF, image, or plain text format and receive instant AI-generated explanations of each biomarker and metric present in the report. The tool covers common lab panels including blood glucose, cholesterol, complete blood count, thyroid markers, and more. It highlights values that fall outside normal reference ranges and flags potential concerns the user may wish to discuss with a healthcare provider. It does not diagnose or prescribe; it explains and contextualizes. LabAnalyzer processes data locally in the browser where possible and states that uploaded data is not retained after the session ends, positioning privacy as a core feature. The platform also supports lab results in multiple languages including English, Korean, Japanese, and Chinese, broadening its accessibility. The primary audience is health-conscious individuals who receive lab results and want a faster, more accessible explanation than waiting for a doctor's interpretation. Pricing starts at approximately $5 per analysis according to third-party listings, making it a low-cost consumer health tool. Note: The company field in the source directory listed 'Zeta Labs' and linked to zetalabs.ai, which is actually the company behind JACE, an unrelated autonomous web agent. LabAnalyzer appears to be an independent product at labanalyzer.org with no verified connection to Zeta Labs. Key features: - Upload lab results as PDF, image, or plain text for instant AI analysis - Explains individual biomarkers (glucose, cholesterol, CBC, thyroid, etc.) in plain language - Flags out-of-range values and suggests discussion points for a doctor - Multi-language support including English, Korean, Japanese, and Chinese - Browser-based processing with no data retained after session ends - Mobile-friendly interface optimized for both desktop and mobile use
Starts at approximately $5 per analysis (per third-party listings); no publicly documented subscription tiers found